Five-year summaries of key financial data
Key figures from consolidated income statement and statement of cash flows
|
millions of CHF |
|
2017 |
2016 |
2015 |
2014 |
2013 |
|
Order intake |
|
3’155.7 |
2’797.5 |
2’895.8 |
3’160.8 |
3’249.9 |
|
Order intake gross margin |
|
34.4% |
34.0% |
33.8% |
33.5% |
33.5% |
|
Order backlog |
|
1’593.5 |
1’439.1 |
1’510.7 |
1’699.6 |
1’672.1 |
|
Sales |
|
3’049.0 |
2’876.7 |
2’971.0 |
3’212.1 |
3’263.9 |
|
Operating income |
EBIT |
136.5 |
115.3 |
120.9 |
–69.0 |
264.0 |
|
Operational EBITA |
opEBITA |
255.4 |
238.9 |
254.1 |
302.9 |
304.1 |
|
Operational EBITA margin (operational EBITA/sales) |
opROSA |
8.4% |
8.3% |
8.6% |
9.4% |
9.3% |
|
Return on capital employed (operational EBITA in % of average capital employed) 1) |
opROCEA |
15.8% |
15.7% |
17.0% |
17.1% |
14.6% |
|
Net income attributable to shareholders of Sulzer Ltd |
|
83.2 |
59.0 |
73.9 |
275 |
234.4 |
|
– in percentage of equity attributable to shareholders of Sulzer Ltd |
ROE |
5.0% |
3.7% |
3.3% |
11.3% |
10.0% |
|
Reported EPS |
EPS |
2.44 |
1.73 |
2.17 |
8.09 |
6.89 |
|
Depreciation |
|
–71.7 |
–69.5 |
–74.1 |
–79.2 |
–73.0 |
|
Amortization |
|
–53.8 |
–47.3 |
–42.3 |
–43.3 |
–41.6 |
|
Impairments 2) |
|
–15.4 |
–18.4 |
–13.0 |
–0.4 |
0.0 |
|
Research and development expenses |
|
–81.0 |
–71.4 |
–73.4 |
–76.2 |
–70.6 |
|
Capital expenditure |
|
81.2 |
74.9 |
73.7 |
96.0 |
80.5 |
|
Free cash flow |
|
127.0 |
200.5 |
155.8 |
98.0 |
218.7 |
|
FCF conversion (free cash flow/net income) |
|
1.46 |
3.34 |
2.08 |
0.35 |
0.93 |
|
Employees (number of full-time equivalents) as of December 31 |
|
14’732 |
14’005 |
14’253 |
15’494 |
15’382 |
|
Personnel expenses |
|
1’078.2 |
971.1 |
1’020.8 |
1’046.2 |
1’047.4 |
1) Since 2014 opEBITA/operational capital employed (excl. other intangible assets). For 2013 and earlier capital employed.
2) Impairments does not include impairment on goodwill.
Key figures from consolidated balance sheet
|
millions of CHF |
|
2017 |
2016 |
2015 |
2014 |
2013 |
|
Non-current assets |
|
1’990.5 |
1’809.9 |
1’574.0 |
1’681.9 |
1’891.5 |
|
– thereof property, plant, and equipment |
|
531.6 |
511.0 |
491.4 |
530.7 |
492.0 |
|
Current assets |
|
2’126.8 |
1’926.0 |
2’680.8 |
2’971.1 |
2’652.4 |
|
– thereof cash and cash equivalents and marketable securities |
|
488.8 |
429.5 |
1’217.3 |
1’301.5 |
528.7 |
|
Total assets |
|
4’117.3 |
3’735.9 |
4’254.8 |
4’653.0 |
4’543.9 |
|
Equity attributable to shareholders of Sulzer Ltd |
|
1’680.1 |
1’581.2 |
2’224.7 |
2’435.4 |
2’334.4 |
|
Non-current liabilities |
|
900.1 |
980.3 |
472.1 |
994.5 |
825.3 |
|
– thereof long-term borrowings |
|
458.7 |
458.3 |
7.2 |
510.3 |
515.9 |
|
Current liabilities |
|
1’514.8 |
1’164.6 |
1’548.5 |
1’216.5 |
1’377.9 |
|
– thereof short-term borrowings |
|
255.1 |
7.1 |
514.4 |
17.7 |
56.6 |
|
|
|
|
|
|
|
|
|
Net liquidity 1) |
|
–225.0 |
–35.9 |
695.7 |
773.5 |
–36.2 |
|
Equity ratio 2) |
|
40.8% |
42.3% |
52.3% |
52.4% |
51.4% |
|
Borrowings-to-equity ratio (gearing) |
|
0.42 |
0.29 |
0.23 |
0.22 |
0.25 |
1) Cash and cash equivalents and marketable securities, less short-term and long-term borrowings
2) Equity attributable to shareholders of Sulzer Ltd in relation to total assets.